Published: Aug 14th, 2014
The UF Health Personalized Medicine Program is conducting an ongoing research study to test the feasibility of preemptive genotyping and to facilitate the gradual expansion of genomic medicine at UF […]
Nov 16th, 2016
This NIH-funded, UF-led study showed that a genetic test can significantly reduce the risk of adverse cardiac events for heart stent patients by helping identify the best antiplatelet medication for each patient.
Feb 28th, 2016
As pharmacogenetic data are increasingly being incorporated into the patient care decision making process, additional information is needed to inform clinician strategies and priorities. An important step in obtaining these […]
Feb 1st, 2016
Daniel Beylik, Pharm.D. Candidate, Class of 2016 Thiopurine agents such as 6-mercaptopurine or azathioprine are used in patients with inflammatory bowel disease (IBD) as well as some pediatric cancers (i.e., […]